Mel‐18, a gene promoter regulator, might affect c‐myc, bcl‐2, cyclin D2, and Hox [50, 51], which induce tumor cell proliferation, metastasis, and angiogenesis [52, 53]. The gene discussed is BCL2; the disease is neoplasm.